Litigation Details for ViiV Healthcare Company v. Cipla Limited (D. Del. 2020)

✉ Email this page to a colleague

The small molecule drugs covered by the patents cited in this case are ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , and ⤷ Sign Up .

Subscribe to access the full database, or Sign Up
Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00				External link to document
2020-07-22	1	Complaint	Plaintiffs’ U.S. Patent Nos. 9,242,986 (“the ’986 Patent”) and 10,426,780 (“the ’780 Patent”). … COUNT II: INFRINGEMENT OF U.S. PATENT NO. 10,426,780 42. Plaintiffs hereby reallege… This is a civil action for patent infringement under the patent laws of the United States, Title… THE PATENTS-IN-SUIT 21. The ’986 Patent, entitled “Synthesis of carbamoylpyridone…986 Patent is attached as Exhibit A. Shionogi & Co., Ltd. is the assignee of the ’986 Patent. ViiV	External link to document
2020-07-22	3	ANDA Form	January 24, 2031 (10,426,780) Thirty Month Stay Deadline… Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) …No earlier than 6/10/2020. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 12/10… SUPPLEMENTAL INFORMATION FOR PATENT CASES INVOLVING AN ABBREVIATED NEW DRUG…, 2020 Date of Expiration of Patent: December 8, 2029 (9,242,986)	External link to document
2020-07-22	4	Patent/Trademark Report to Commissioner of Patents	Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,242,986; 10,426,780. (nmg) (Entered…2020 14 March 2023 1:20-cv-00977 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document